Signature Equity Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$80.5K Sell
364
-22
-6% -$6.09K 0.04% 341
2026
Q1
$114K Sell
386
-26
-6% -$7.72K 0.06% 266
2025
Q4
$112K Buy
+412
New +$112K 0.06% 253

Other funds holding CME

Signature Equity Partners's CME Position: Q2 2026 in Review

Signature Equity Partners reduced its CME Group (CME) stake by 5.7% in Q2 2026, selling an estimated $6.09K and leaving 364 shares worth $80.5K. The position accounts for 0.04% of the portfolio, ranked #341.

Signature Equity Partners first reported a position in CME in Q4 2025 and has held it in 3 quarters since. The position peaked at $114K in Q1 2026. 1,701 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Signature Equity Partners held 364 shares of CME Group worth $80.5K as of Q2 2026.
  • Signature Equity Partners sold 22 CME Group shares in Q2 2026, an estimated $6.09K.
  • CME Group made up 0.04% of Signature Equity Partners's portfolio in Q2 2026, its #341 holding.
  • Signature Equity Partners first reported a position in CME Group in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's CME Group position peaked at $114K in Q1 2026.
  • 1,701 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.